Rajitha Grace 2018 Irrevocable Trust - 27 Aug 2021 Form 3 Insider Report for Acasti Pharma Inc. (GRCE)

Reporting relationship: 10%+ Owner
Issuer ticker: GRCE
Reported as of: 27 Aug 2021
Net transaction value: $0
SEC form: 3
Accepted by SEC: 23 Sep 2021, 16:33:54 UTC
Source filing: View source filing
Reporting owner signature: /s/ Jason Comerford, Attorney-in-Fact

Key filing fact

Rajitha Grace 2018 Irrevocable Trust filed Form 3 for Acasti Pharma Inc. (GRCE) on 23 Sep 2021.

Key facts

This page summarizes Rajitha Grace 2018 Irrevocable Trust's Form 3 filing for Acasti Pharma Inc. (GRCE).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 23 Sep 2021, 16:33.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ACST holding

CLASS A COMMON SHARES

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,689,547
Date: 27 Aug 2021
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

Remarks: The trustee of the Rajitha Grace 2018 Irrevocable Trust is Swami Sambamurty Iyer. Mr. Iyer disclaims beneficial ownership over the shares except to the extent of his role as trustee. Exhibit List - Exhibit 24 - Power of Attorney